Navigation Links
Pregnancy exposures determine risk of breast cancer in multiple generations of offspring
Date:9/11/2012

WASHINGTON, DC Researchers from Georgetown Lombardi Comprehensive Cancer Center demonstrate, in animals, that maternal exposure to a high-fat diet or excess estrogen during pregnancy can increase breast cancer risk in multiple generations of female offspring daughters, granddaughters and even great-granddaughters.

This study, published online today in Nature Communications, shows for the first time that the risk of some "familial" breast cancers originate from biological alterations caused by maternal diet during pregnancy that not only affect the directly exposed fetus but also the fetal germ cells, transmitting the increased mammary cancer risk to subsequent generations.

This study also provides some hints about the biological mechanisms behind this multi-generational transmission of risk. The researchers found that maternal intake of high-fat diets and excess estrogens changes DNA methylation patterns in the offspring's breast and make it more sensitive to carcinogens later in life. Importantly, these traits are inheritable.

"We know that maternal diet can have long lasting effects on an offspring's health, but this study demonstrates, for the first time, that a high fat diet or excess estrogen can affect multiple generations of a rat's offspring, resulting in an increase in breast cancer not only in their daughters, but granddaughters and great granddaughters," says the study's senior investigator, Leena Hilakivi-Clarke, Ph.D., a professor of oncology at Georgetown Lombardi.

The research team, which includes investigators from institutions in Finland and the United States, tested three groups of pregnant rats and their progeny. The two exposed groups of rats were at heightened risk for developing breast cancer, compared to the control group.

In the first group, rats were fed a high fat diet before conception and throughout pregnancy. Breast cancer risk was increased by 55 to 60 percent in the daughters and granddaughters of rats given a high fat diet during pregnancy compared to the offspring of control rats which ate a normal diet during pregnancy. The increased risk did not extend to the great-granddaughters of high-fat fed rats.

"We also found that if the mother was fed a high fat diet before conception and throughout pregnancy, the risk of increased breast cancer was transmitted to granddaughters through either males or females exposed to the high fat diet in utero," says the study's lead investigator, Sonia de Assis, Ph.D., a postdoctoral researcher in Hilakivi-Clarke's laboratory.

In the other group, rats were fed a diet supplemented with estrogen during the last week of pregnancy, and the control rats were fed a normal diet. The researchers found a 50 percent higher incidence of breast tumors in the exposed rats' daughters, granddaughters, and great-granddaughters, compared to the control group. In this case, increased breast cancer risk was transmitted to granddaughters through the in utero estrogen exposed females only.

Both the high-fat and excess estrogen diets produced breast tissue in the affected generations of female offspring that had more than the normal number of terminal end buds, structures that are the building blocks of mammary epithelial tree and primary targets for carcinogens.

The researchers also documented epigenetic changes in the mammary glands of all three generations of pregnant rats exposed to estrogen.

"Germ cells cells involved in reproduction first develop during the fetal period and in utero exposures, such as the ones in our study, could disrupt their normal epigenetic marks and affect how genes are turned on or turned off," de Assis says. "Those alterations then can be passed on and affect the risk of disease, in this case breast cancer, in subsequent generations."

Hilakivi-Clarke points out that two-thirds of human familial breast cancers have no known genetic mutations. She says the effect seen from a high-fat diet and excess estrogens may help explain some of those cases and link them to inherited epigenetic changes.

"We know from human studies that daughters whose mothers took the synthetic estrogen diethylstilbestrol (DES) to reduce pregnancy complications, or who had a birth weight of more than 8.8 pounds are at an increased risk of developing breast cancer. Our study suggests their offspring may also be at risk," Hilakivi-Clarke says.

"This study suggests directions for future research in women. Could a woman's susceptibility to breast cancer development be determined by what her grandmother ate when she was pregnant, or if she was exposed to high levels of estrogen perhaps unwittingly, through the environment?" asks de Assis.

The researchers add that there is potential good news epigenetic inheritance of breast cancer risk might be detectable through blood testing, and that, in particular, the adverse effects of an exposure to excess estrogen in utero is, possibly, reversible.

"Our on-going preclinical studies have found that the increase in breast cancer risk caused by in utero exposure to excess estrogens can be reversed by drugs that reverse epigenetic marks chemical modifications that turns genes on and off caused by the exposure . These drugs, called HDAC and DNMT inhibitors, are being used, with success, in humans to treat some cancers," Hilakivi-Clarke says. Hilakivi-Clarke is one of the inventors on Georgetown University-owned HDAC inhibitor and DNMT inhibitor patents.

"It's easy to see how this study possibly has human health implications to be considered since fatty foods are endemic in our society, and low levels of chronic exposure to endocrine disruptors substances that have hormonal activity such as estrogen have been found in food and drinking water," says de Assis.


'/>"/>

Contact: Karen Mallet
km463@georgetown.edu
Georgetown University Medical Center
Source:Eurekalert

Related medicine news :

1. Breast cancer risks acquired in pregnancy may pass to next 3 generations
2. Rise in Pregnancy-Associated Cancers Not Fully Explained by Older Age
3. Teen Obesity Linked to Moms Smoking in Pregnancy: Study
4. No Truth to Candidates Claim That Rape Hinders Pregnancy, Experts Say
5. Smoking During Pregnancy May Cause Asthma, Wheezing in Kids
6. Smoking during pregnancy increases the risk of wheeze and asthma in preschool children
7. High-Potency Pot in Pregnancy May Cause Brain Damage
8. Chemo During Pregnancy Doesnt Seem to Harm Newborn
9. Drinking in Pregnancy Shows Up in Childs Growth: Study
10. Pregnancy May Raise Risk of Cerebral Bleeding in Some Women
11. Experts issue recommendations for treating thyroid dysfunction during and after pregnancy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... (PRWEB) , ... April 28, 2016 , ... Metabolic ... supplement GlycoLoad at this week’s 2016 Europa Games Get Fit and Sports Expo ... consumers alike, the Europa Orlando Expo coming up April 29-30, was selected as the ...
(Date:4/28/2016)... ... ... The Aging in Motion Coalition (AIM) has announced the Centers for ... recognition for separate reporting and data collection. The code, M62.84, will be available for ... a combination of low muscle mass and weakness in older adults that causes functional ...
(Date:4/28/2016)... ... April 28, 2016 , ... Prescription ... co-operative bankruptcy to receive their prescription medications through America’s fastest-growing pharmacy program. ... medications from over 180 American pharmaceutical companies for $35 per month, per ...
(Date:4/28/2016)... ... April 28, 2016 , ... ... latest offering, the Protocol Calendar Exchange , is officially open to all ... protocol calendars available for sites to download into their clinical trial management system ...
(Date:4/28/2016)... ... April 28, 2016 , ... ... Medical Officer at the Steadman Philippon Research Institute in Vail, Colorado, attended the ... raise awareness about the debilitating and costly musculoskeletal disorders that are affecting millions ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... , April 28, 2016 ... insights on healthcare, announced today that it has been ... Cool Vendor in Life Sciences, 2016, ... 2016.  The report focuses on life-science- oriented analytics, algorithms ... from patients and doctors, confirm medication ingestion, and analyze ...
(Date:4/28/2016)... FREMONT, Calif. , April 28, 2016 ... Enterprise Validation Lifecycle Management Solutions (VLMS) today ... products and services for sufferers of chronic ... management System to manage their corporate validation ... been seeking a software solution to manage ...
(Date:4/27/2016)... 27 Avril 2016   ... de +5% sur le trimestre, soutenu par une ... Croissance de +16% des ventes aux ... Mauna Kea Technologies (Euronext : MKEA, FR0010609263 ; OTCQX : MKEAY), ... annonce aujourd,hui son chiffre d,affaires pour le premier ...
Breaking Medicine Technology: